Author:
Faghihkhorasani Amirhosein,Ahmed Hanan Hassan,Mashool Noor Muhammad,Alwan Mariem,Assefi Marjan,Adab Aya Hussein,Yasamineh Saman,Gholizadeh Omid,Baghani Moein
Abstract
AbstractViral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus.
Graphical Abstract
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献